Nanobiotix (NBTX) Receivables (2019 - 2025)
Nanobiotix (NBTX) posted Receivables of $4.1 million for Q4 2025, down 35.05% on a QoQ basis from $6.4 million in Q4 2024, and down 35.05% year-over-year from $6.4 million in Q4 2024.
Nanobiotix (NBTX) has 7 years of Receivables data on file, last reported at $4.1 million in Q4 2025.
- In Q4 2025, Receivables fell 35.05% year-over-year to $4.1 million; the TTM figure through Dec 2025 stood at $4.1 million (down 35.05% YoY), while the FY2025 annual figure was $4.0 million, down 37.76% from the prior year.
- Receivables fell to $4.1 million in Q4 2025, from $6.4 million in the prior quarter.
- Across five years, Receivables topped out at $6.4 million in Q4 2024 and bottomed at $2.5 million in Q4 2023.
- A 5-year average of $4.0 million and a median of $3.9 million in 2021 frame the typical range for Receivables.
- Annual changes were most pronounced in 2021 — Receivables jumped 230.05% — and 2025, when it slumped 35.05%.
- Year by year, Receivables stood at $3.9 million in 2021, then retreated by 24.97% to $2.9 million in 2022, then dropped by 13.99% to $2.5 million in 2023, then surged by 155.96% to $6.4 million in 2024, then tumbled by 35.05% to $4.1 million in 2025.
- The last three Receivables figures came in at $4.1 million (Q4 2025), $6.4 million (Q4 2024), and $2.5 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 13.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 4.15 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.00 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.73 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 883.96 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.97 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Dec 31, 2024 | 4.37 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Dec 31, 2023 | 2.49 Mn |
| Jun 30, 2023 | 1.19 Mn |
| Dec 31, 2022 | 2.90 Mn |
| Jun 30, 2022 | 253,959.49 |
| Dec 31, 2021 | 3.86 Mn |
| Dec 31, 2020 | 1.17 Mn |
| Dec 31, 2019 | 1.39 Mn |